December 21, 2022

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Nerve block an effective treatment for painful shoulder condition

Differences between the active and placebo groups until the time of resolution: (A) active abduction ROM, (B) total SPADI % score, (C) VAS, (D) the perceived rate of recovery. ROM, range of motion; SPADI, Shoulder Pain and Disability Index; VAS, Visual Analog Scale. Credit: RMD Open (2022). DOI: 10.1136/rmdopen-2022-002648
× close
Differences between the active and placebo groups until the time of resolution: (A) active abduction ROM, (B) total SPADI % score, (C) VAS, (D) the perceived rate of recovery. ROM, range of motion; SPADI, Shoulder Pain and Disability Index; VAS, Visual Analog Scale. Credit: RMD Open (2022). DOI: 10.1136/rmdopen-2022-002648

Treating the painful shoulder condition adhesive capsulitis with a nerve block is a safe, simple and effective treatment, according to recent results from a Flinders-led clinical trial.

Also known as frozen shoulder, adhesive capsulitis is a common shoulder condition is unknown and current that results in stiffness and pain in the . Its cause treatment options remain unsatisfactory for most patients.

Led by Professor Michael Shanahan, Professor in Musculoskeletal Rheumatology Medicine at Flinders University and Director of the Rheumatology Unit at Flinders Medical Center, the trial assessed the efficacy of suprascapular nerve block—an injection around a major sensory nerve for the shoulder which runs from the neck into the shoulder region—for the management of frozen shoulder.

From a total of 54 patients, 27 received a into the shoulder joint, along with physiotherapy and the suprascapular nerve block at the 3-monthly intervals, while the other 27 patients received the steroid injection and physiotherapy with a placebo .

"We found those who received the nerve block reduced the duration of their symptoms by an average of 6 months, while also reporting lower pain and disability scores and improved range of movement, compared to the ," says Professor Shanahan.

"For patients in the placebo group, the average time for their symptoms to resolve was over 11 months, while for those who received the nerve block this was practically halved, down to around 5 and half months."

The authors say the clinical trial establishes that a suprascapular nerve block is a valuable and for frozen shoulder.

"Up to 5% of the population are known to have a frozen shoulder at some point in their lives, and the incidence among people with diabetes or a prior stroke is especially high, so it's important we find effective long-term solutions," says Professor Shanahan.

"Previous research has shown that treatment with steroid injections and physiotherapy can help improve the symptoms of frozen , but this trial shows that the addition of the nerve block can have much greater benefits, likely due to its role in reducing pain, thereby allowing patients to work harder at improving their range of movement."

Due to the ease, low cost and efficiency of delivering the therapy in a , alongside its previously established safety, the authors say the treatment could be confidently implemented today.

The paper, "Suprascapular block for the treatment of adhesive capsulitis: a randomised double-blind placebo-controlled trial," is published in the journal RMD Open.

More information: E Michael Shanahan et al, Suprascapular nerve block for the treatment of adhesive capsulitis: a randomised double-blind placebo-controlled trial, RMD Open (2022). DOI: 10.1136/rmdopen-2022-002648

Load comments (0)